We aimed at estimating additive genetic heritability, household component effect and the influence of common alleles of the apolipoprotein E gene (APOE) on serum high-sensitivity C-reactive protein (hs-CRP) concentrations and the subsequent changes over 5 years. A sub-sample of 320 nuclear families was randomly selected from the Stanislas Family Study. Serum hs-CRP concentration was measured by immunonephelometry at entrance and after 5 years. APOE alleles were determined by restriction fragment length polymorphism. After adjustment for covariates, the number of the e4 allele was negatively associated with serum concentration of hs-CRP in the whole sample, at entrance and 5 years later, without significant interaction with sex by generation groups (P ¼ 0.003 and P ¼ 0.0003, respectively). However, no significant association was found between e4 allele and 5-year changes in hs-CRP concentration. Using a variance component analysis, no significant genetic influence was shown in family aggregation of both hs-CRP measurements and 5-year changes; the household common component was between 6.5 and 12.8%. In addition, after adjustment for APOE gene polymorphisms, degrees of resemblance were almost unchanged. In the Stanislas Family Study, e4 allele of the APOE gene was associated with lower hs-CRP concentration, but not with 5-year changes. However, variance component analysis did not evidence a significant polygenic effect.
Introduction
Over the past decade, we have come to appreciate a prominent role of inflammation in atherosclerosis and its complications. 1 Research led to the recommendation of a first inflammatory molecule, the high-sensitive C-reactive protein (hs-CRP), by the Centers for Disease Control and Prevention (CDCP) and the American Heart Association (AHA) as an additional marker of cardiovascular (CV) diseases. 2 Indeed, high hs-CRP levels were significantly associated with increased CV risk. 3 In addition, several major CV risk factors are associated with elevated hs-CRP levels, including smoking, 4 obesity, 5 metabolic syndrome 6 and diabetes. 7 In view of the importance of hs-CRP concentration, several teams investigated its genetic heritability in various populations of middle-aged adults or elderly. The twin studies estimated genetic heritability ranged between 22 and 56%, [8] [9] [10] [11] while studies based on individuals from large pedigrees showed that polygenic component accounted for lower values (between 28 and 39% of total variance). [12] [13] [14] However, a recent family study concluded to have no polygenic effect in heritability of hs-CRP level. 15 Several polymorphisms in the CRP gene have been investigated and were related to hs-CRP concentration. 16, 17 Moreover, some other gene polymorphisms were associated with circulating levels of the hs-CRP, the most studied being the common polymorphisms of the apolipoprotein E gene (APOE) (e2, e3, e4) for which an association was confirmed by many authors in adults and elderly. 12, [18] [19] [20] [21] [22] [23] [24] However, no data exist either about APOE genotype-hs-CRP concentration association in children or about effect of these polymorphisms in combination with estimate of heritability component. 12 Thus, in the present analysis, we aimed at reporting on (i) the association between the APOE gene alleles with the serum hs-CRP concentration in adults and also in children, (ii) the familial aggregation of the serum hs-CRP concentration on a sample of French nuclear families and on (iii) the variance-component genetic linkage of this inflammatory factor with the alleles of the APOE gene. These studies were conducted on a subsample of the Stanislas Family Study, at entrance and 5 years later.
Results
Characteristics of the sample at entrance and at the second checkup are summarized in Table 1 . The distribution of APOE genotype frequencies was in accordance with Hardy-Weinberg equilibrium expectation.
Regression analyses showed that the number of e4 allele but not the e2 one was negatively associated with the concentration of hs-CRP at the two checkups in the whole sample (Table 2 ). This association remained significant even after adjusting for the covariates: age, sex, body mass index (BMI), alcohol and tobacco consumption, glucose and triglyceride concentrations and contraceptive and anti-inflammatory use (P ¼ 0.003 and P ¼ 0.0003, respectively). No significant interaction was found with sex by generation groups. However, when analysis was done separately in fathers, mothers, sons and daughters, regression coefficient remained significant in fathers and mothers only. In our sample, e4 allele frequency explained only a modest part of hs-CRP concentration variance (0.5 and 0.7%, respectively at the two checkups). However, covariates used in the regression model together with e4 allele frequency explained 31.2 and 35.1% of total variance of hs-CRP concentration, respectively at the two checkups. No significant association was found between e4 allele and 5-year changes in hs-CRP concentration by using crude or adjusted values (data not shown).
The pattern of family correlations is given in the Supplementary Table S1 (see Supplementary Information) for adjusted hs-CRP concentrations at the first and the second checkups and for the 5-year changes. The most parsimonious model for each trait (no gender effect on parent and offspring correlations) appears in Table 3 . At entrance, spouse, parent-offspring, and offspringoffspring correlation coefficients were statistically significant: 0.149, 0.114 and 0.196, respectively. At the second checkup, correlation coefficients were 0.069, 0.107 and 0.171, respectively for the three pairs of relatives, spouse correlation being no longer significant. The 5-year changes significantly correlated only in siblings: 0.107, 0.048 and 0.170, respectively. Additional adjustment for e4 allele frequency did not significantly modify level and significance of correlation coefficients for the three traits (data not shown).
Results from variance component analysis are presented in Supplementary Tables S2 and S3 in online  appendix and are summarized in Table 4 . At entrance and after 5 years, the full model (Model 1) with six components, additive polygenic variances, household common variances and residual variances separating parent and sibling were rejected for a simpler model with three components having equal effect in parents and offspring (Model 2). When checking the hypothesis of no household, no polygenic component or no household and no polygenic component effects, the most parsimonious model was Model 4, which took into account only shared environmental (11.0-12.8%) and residual variances (87.2-89%) with a better Akaike's Information Criterion (AIC).
Concerning the 5-year changes in hs-CRP concentration (Supplementary Table S3 and Table 4 ), the most parsimonious model was the one that took into account only shared environmental and residual variances, separating spouses and children with a better AIC (Model 4). This model assumed that variance components were Geometric means (range of 1 s.d.).
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generation-dependent with a greater absolute variance in children than in parents: 0.149 and 0.101, respectively. However, relative contribution of household effect was almost similar (6.5-7.6%). Adjustment for the e4 allele frequency of the APOE gene significantly improved neither the log-likelihood function nor the altered variance component values.
Discussion
The association between the common polymorphisms of APOE gene and the hs-CRP concentration was already reported in the elderly, 18, 19 in dyslipidemic adults, 22 in type II diabetes 24 and in families. 12 However, there is no data about association between the APOE genotype and Table A1 in online appendix.
Heritability of serum hs-CRP concentration H Berrahmoune et al the hs-CRP concentration in children. In the present study, we found that the e4 allele was negatively associated with hs-CRP concentrations in our group of 1223 individuals independent of the covariates used, including triglyceride concentration, and without age Â generation interaction. In the literature, the mechanism through which e4 allele is negatively associated with hs-CRP concentrations remains unclear. This effect does not seem to be related to inflammation process because both fibrinogen and white cell count, two markers of systemic inflammation, were not associated to the APOE genotype. 21 However, it was suggested that production, release or catabolism of CRP are related to the activity of the mevalonate pathway in the liver. 21 Indeed, in carriers of APOE e4 allele, the flux of intestinal cholesterol in hepatocytes increases in comparison to other genotypes. As a consequence, hepatic cholesterol biosynthesis decreases, 25, 26 leading to the downregulation of the mevalonate pathway in addition to CRP. Moreover, statins, which inhibit the major rate limiting step of the mevalonate pathway, namely the conversion of HMGCoA into mevalonate, have consistently been shown to lower CRP. 27 Meanwhile, a recent study suggested that the contribution of the e4 allele towards lowering CRP levels is independent and may be by a different mechanism than how statins affect inflammation. 19 However, implication of lipoprotein pathway of the cholesterol transport remained plausible since Schwalbe et al. 28 reported that CRP may be complexed with lipoprotein by a direct interaction with the apolipoprotein E molecule, suggesting a direct effect of the APOE e4 allele on hs-CRP concentration.
This study of French families showed moderate familial influence on serum hs-CRP concentration but without significant genetic effect. At entrance, correlation coefficients between the three pairs of relatives were significantly different from 0. In addition, spouse correlation (r ¼ 0.149) was higher than that between parent and offspring (r ¼ 0.114) suggesting absence of a genetic influence. After 5 years, spouse correlation coefficient decreased and was no longer significant (r ¼ 0.069); parent-offspring and sibling correlations being not substantially modified (r ¼ 0.114-0.107 and r ¼ 0.196-0.171, respectively). For the 5-year changes, only sibling correlation remained significant (r ¼ 0.170). Decomposition of variance confirmed the results of family correlations. For both measurements of hs-CRP at entrance and after 5 years, and changes between the two checkups, no significant polygenic effect on family resemblance was found. Estimates given by models were negative for two traits (at entrance and for 5-year changes) and for hs-CRP concentration at the second checkup; models including additive polygenic variance were rejected. Whatever the trait, the most parsimonious model was that which took into account only shared environmental (6.5-12.8%) and residual variances. When the effect of e4 allele of the APOE gene was checked in familial correlation and variance component models, results were almost unchanged. This could be due to the modest effect of the e4 allele on hs-CRP concentration and the non-significant additive polygenic variance found in our study.
Comparison of our results with those of studies in the literature (Table 5 ) must take into account various criteria such as the characteristics of the population sample (age, sex, life style, environment, degree of kinship, ethnic origin, genetic background and so on), the study design (twin study, sibships, nuclear families of various type and size or more complex pedigrees), the exclusion criteria (cutoff of hs-CRP concentration, diseases, drug use, age and so on), the covariates used in analysis (age, BMI, smoking and so on) and statistic method used to estimate heritability that can be done in different ways, including comparison of the within-pair similarity between monozygote (MZ) and dizygote (DZ) twins, variance-component linkage analysis in pedigrees of unlimited size and complexity or variance component analysis for nuclear families. In addition, in some studies based on individuals from large and complex pedigrees, only the whole heritability was estimated without separating polygenic and common household components.
In nuclear families, sibling correlations were higher than those found in the present study (0.18-0.30) and spouse correlations were generally not significant 12, 29 ( Table 5) . In twin studies, within-pair correlations were even higher: 0.40-0.49 and 0.17-0.28, for MZ, 9, 10, 30 and DZ twins, 9,10 respectively. In addition, there is a Tables A2 and A3 in online appendix.
Heritability of serum hs-CRP concentration H Berrahmoune et al discrepancy between most of the previous familial and twin studies investigating the hs-CRP concentration heritability and our results, since they reported a significant and higher polygenic effect (between 20 and 52%) [8] [9] [10] 12, 13 (Table 5) , while we found no genetic effect on hs-CRP concentration heritability. However, our results are in accordance with those of Friedlander et al. 15 who reported no polygenic effect for hs-CRP concentrations and the changes of over 10 years.
Difference with our results, particularly difference or overestimation of heritability, could be due to three main issues: (a) genotypic variance may include shared environmental variance that has not been removed by design or analysis (mainly in twin study when equal environment assumption might be invalid), (b) estimates could greatly differ across populations according to the distribution of environmental and genetic factors and (c) the assumption of independence between genotype and 
Materials and methods

Population studied
The Stanislas Family Study is a 10-year longitudinal survey involving 1006 volunteer families whose members were free of chronic disease and were of a French origin. At entrance, families were enrolled during a free health checkup at the Centre for Preventive Medicine in Vandoeuvre-lès-Nancy (France). During 1999-2000, 750 families attended the second checkup and 320 were randomly selected for the present study (1223 individuals). 31 In addition, individuals with aspartate aminotransferase, alanine aminotransferase, or g-glutamyl transferase activities 4200 U/l; orosomucoid or haptoglobin concentrations 43 g/l, hs-CRP 410 mg/l, cholesterol or triglyceride concentrations 410 mmol/l or glucose concentration 48 mmol/l were excluded. Participants using anti-inflammatory drugs were not excluded. The research protocol was approved by the 'Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale de Lorraine' and each subject gave a written informed consent.
Blood samples and laboratory methods Data were collected by using relevant questionnaires including information about lifestyle such as tobacco, alcohol and drug consumption and personal medical history. Physical examinations and functional tests were performed and basic blood constituents were measured as previously described. 32 Serum hs-CRP was measured by immunonephelometry (Nephelometer Analyser BN II, Dade-Behring, Marburg, Germany) using Behring reagents (DadeBehring, Rueil-Malmaison, France). Two hs-CRP control samples were run with each batch of samples. Results were not released until all controls were within the expected limits. Within-run imprecision was 3.2% for an hs-CRP level of 5.0 mg/l and between-run imprecision 6.1% for an hs-CRP level of 11.4 mg/l. The minimum detectable level of this assay is 0.17 mg/l. Subjects with values at or below this value were coded as 0.17 mg/l for statistical analyses.
The APOE polymorphisms were determined by a restriction fragment length polymorphism method described previously. 33 
Statistical analysis
Values of hs-CRP concentrations, at entrance and 5 years later, were log 10 -transformed in all analyses to improve normality. A w 2 test was performed to determine whether genotype frequencies were in Hardy-Weinberg equilibrium.
Regression coefficients were computed to determine the quantitative effect of the covariates and the polymorphisms using an allelic model for the overall sample and for the four sex Â generation groups (fathers, mothers, sons and daughters). In addition, significance of differences in regression coefficients between fathers, mothers, sons and daughters was assessed by testing interaction terms between each covariate and the four groups in the overall sample. As individuals within a family are not independent, statistical analyses were based on the estimating equation technique by using the SAS GENMOD procedure with a repeated statement. Statistical analyses for individuals were performed by using the SAS software package version 9.1 (SAS Institute Inc., Cary, NC, USA).
For familial correlations and variance component analysis, values at entrance and for the second checkup were log 10 -transformed and adjusted for age, BMI, alcohol consumption, smoking, serum glucose and triglyceride concentrations, and oral contraceptive and anti-inflammatory drug use. The 5-year changes were calculated as the difference in log 10 -transformed values and adjusted for the above covariates at the two checkups; differences being then adjusted for entrance values.
Linear intra-familial correlations were estimated by using maximum likelihood techniques 34 with the COR-FAM program. The general model estimating all eight correlation coefficients for two classes of relatives (father-son, mother-son, father-daughter and motherdaughter) and for a single class of relatives (spouses, brother-brother, sister-brother and sister-sister) was compared to submodels, estimating correlation coefficients without accounting for parent's and/or child's sex. The significance of various familial correlations or sex and generation differences in correlations were tested by using the log-likelihood ratio test. In addition, the effect of the common APOE polymorphism was checked in the models.
Variance component analysis was applied to assess the relative contributions of genetic, common household factors and individual-specific environment in family aggregation of serum hs-CRP concentrations. The analysis was conducted by using a multivariate normal model for pedigree analysis as described by Lange et al. 35, 36 with the software FISHER, which also performed tests of goodness of fit of the underlying multinormal distribution. The general models assumed that the studied trait was the result of the sum of three independent random components: a polygenic component (G) representing additive genetic factors, household factors common to individuals within a family (H) and unmeasured environmental factors particular to an individual (including measurement error) (E) with the hypothesis of equality of their effect in the four groups of relatives. These three components were assumed to be normally distributed with mean equal to 0 and variance equal to s 2 G, s 2 H and s 2 E, respectively. To avoid problems of convergence due to values too close to zero, we used in component analysis the trait multiplying by 10. We first analyzed our data using a full model that allowed ousiotype by generation (parents and siblings), and the hypothesis of difference in parts of component variances according to generation was checked. Then, the hypothesis of no household, no polygenic component or no household and no polygenic component effect was checked by comparing nested models. Finally, the effect of the common polymorphism of the APOE gene (e4 and e2) was verified using the allelic model. Comparison of nested models was based on the likelihood ratio criteria. Eventually, the best parsimonious model was selected. AIC ¼ w 2 À2d.f. (degrees of freedom) was used to indicate additional goodness of fit. 37 The smaller or more negative the AIC, the better the parsimony and fit of a model. The contribution (in percents) of the three components, additive genetic factors (heritability), household factors and residual environmental, to residual phenotypic variance (after adjustment for covariates) was deduced.
